Mounjaro, Wegovy and Modern Weight Loss Treatments In The UK: What Has Changed?

Weight management has changed significantly in recent years. Lifestyle measures such as balanced nutrition, regular physical activity and adequate sleep remain central, but prescription medicines are now playing a larger role for some adults who meet the relevant clinical criteria.

Treatments such as Mounjaro and Wegovy have attracted considerable attention because they influence biological pathways involved in appetite, fullness and food intake. They are not suitable for everyone, but they have changed the way medically supported weight management is discussed.

How Mounjaro Works

Mounjaro contains tirzepatide, a medicine that acts on both GLP-1 and GIP receptors. These hormone pathways are involved in appetite regulation, blood glucose control and metabolic function.

For suitable patients, Mounjaro is taken once weekly. Treatment usually begins at a lower dose before being increased gradually, allowing the body time to adjust.

Its effects on appetite can help some people feel satisfied after eating smaller amounts of food, which may make a reduced-calorie eating pattern easier to maintain.

However, treatment should only begin after an appropriate medical assessment. Existing health conditions, current medicines, previous treatment history and potential contraindications all need to be considered.

How Wegovy Is Different

Wegovy contains semaglutide and primarily targets the GLP-1 receptor.

It is also used as a once-weekly treatment, with the dose increased gradually over time. By mimicking the effects of naturally occurring GLP-1, semaglutide can help reduce hunger and increase feelings of fullness.

Although Wegovy and Mounjaro are often discussed together, they are not the same medicine. They contain different active ingredients and act on different hormonal pathways.

This means one treatment cannot automatically be substituted for another without clinical guidance.

Why Weight Loss Injections Have Become Popular

Modern weight loss injections work by influencing biological signals associated with hunger and satiety.

For some people, controlling appetite has historically been one of the most difficult aspects of weight management. Medicines that strengthen fullness signals may make it easier to reduce portion sizes and maintain healthier eating habits.

The MHRA provides guidance on GLP-1 medicines used for weight loss and diabetes, including information about their appropriate use and potential risks.

Medication is still only one part of weight management. Nutrition, exercise, sleep and behavioural changes remain important throughout treatment.

Are Tablets Becoming Part of Weight Management?

Injectable treatments are no longer the only medicines being considered for weight management.

Oral treatments are also becoming part of the wider treatment landscape, giving some patients an alternative to injections.

However, tablets and injectable medicines are not necessarily interchangeable. Different treatments have their own dosing instructions, mechanisms of action, eligibility requirements and safety considerations.

The most appropriate option should therefore be based on individual circumstances rather than convenience alone.

Common Side Effects

Digestive symptoms are among the most commonly reported side effects associated with GLP-1 and related weight management medicines.

These can include:

• Nausea
• Vomiting
• Diarrhoea
• Constipation
• Indigestion
• Abdominal discomfort

Eating smaller meals, avoiding very rich foods and maintaining adequate hydration can sometimes help. Persistent, severe or unusual symptoms should always be discussed with a healthcare professional.

What Happens After Weight Loss?

Losing weight and maintaining weight loss are not always the same challenge.

When appetite-suppressing treatment is stopped, hunger may gradually become more noticeable again. This can make long-term lifestyle habits particularly important.